Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added the NEJM 2015 paper by Larkin et al. on Combined Nivolumab and Ipilimumab for untreated melanoma; removed the Erratum entry for that publication.
    Difference
    0.0%
    Check dated 2026-04-02T04:56:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T19:34:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:56:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Publications section updated: two new articles added and one article removed.
    Difference
    0.1%
    Check dated 2026-03-04T15:09:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-government-funding notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T10:01:33.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a Publications reference for Larkin et al. (Combined Nivolumab and Ipilimumab in untreated melanoma) replacing the older Larkin et al. NEJM citation, and a site-wide notice about government funding and NIH status was also added.
    Difference
    0.4%
    Check dated 2026-02-04T06:49:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.